Sei sulla pagina 1di 2

Carisk Partners Appoints Alana Letourneau, MD, MBA to Chief Clinical

Strategy Officer

Miami, FL, January 20, 2021 --(PR.com)-- Carisk Partners (Carisk), a specialty risk transfer and care
coordination company, is pleased to announce the promotion of Alana Letourneau, MD, MBA to Chief
Clinical Strategy Officer, effective immediately. Dr. Letourneau will continue to report to Joseph
Berardo, Jr., CEO, Carisk. With this latest promotion, Dr. Letourneau will oversee the Carisk Physician
team across all lines of business with continued responsibility for the Quality and Clinical Data teams.

“I truly believe that Alana’s analytical mind, inclusive demeanor, organized process and hard work have
been a major catalyst in driving us where we are today,” says Berardo. “Under Alana’s leadership I am
confident we will continue to demonstrate to the market there is a different way to look at, and manage,
the clinical needs of our patients, and the social and emotional support, they and their families need.”

Dr. Letourneau originally joined Carisk as Vice President, Clinical Program Strategy in 2017 and quickly
demonstrated extraordinary competencies that led to greater responsibilities and advancement to SVP in
2019. Dr. Letourneau has played an instrumental role in the development of clinical operations and
technology systems within Carisk Outcomes. She has also been responsible for key clinical quality
initiatives and data analytics projects within Carisk Behavioral Health and Carisk Intelligent
Clearinghouse, respectively. With this latest promotion, Dr. Letourneau will continue to be responsible
for the company’s clinical, operations, data, and quality initiatives and with oversight from Berardo, will
continue working directly with sales and marketing.

Dr. Letourneau earned a joint Medical Degree and Master of Business Administration from New York
University. Previous to that achievement, she earned a BA from Princeton University, with a major in
Psychology, concentration in Neuroscience and minor in Global Health and Health Policy. Dr.
Letourneau has been recognized as an NJBiz 40 Under 40 Award recipient and demonstrated experience
in clinical operations, neuroscience research, data analytics and health technology.

About Carisk Partners


Carisk is a specialty risk transfer, care coordination company serving insurers, government entities,
self-insured plan sponsors and other managed care organizations. With a foundation in behavioral health,
Carisk’s end-to-end combined solutions include risk-transfer and care coordination of delayed recovery,
complex catastrophic cases and MBHO services. Carisk’s Pathways 2 Recovery program guarantees to
improve outcomes and reduce overall cost of quality care by applying best practices and a
patient-centered approach to manage complex challenges for the Group Health, Casualty and Auto
markets. Carisk is the first and only Managed Behavioral Healthcare Organization with dual
accreditations from both the National Committee for Quality Assurance (NCQA) and the Accreditation
Association for Ambulatory Healthcare, Inc. (AAAHC). Visit www.cariskpartners.com to learn more.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Carisk Partners
Paige Grogan
732-804-0388
Contact via Email
cariskpartners.com

Online Version of Press Release:


You can read the online version of this press release at: https://www.pr.com/press-release/829294

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use